Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
Quick Stats
Apr 06, 202659.0
AI Score
HOLD0.23
Volume Ratio
May 12, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
CAPR Stock Summary
Last updated Apr 06, 2026
CAPR is currently trading at $32.21, positioned above its 200-day moving average of $15.52, indicating a long-term uptrend. The stock has a 52-week range of $4.3 to $40.37.
Technical Analysis: The 50-day moving average stands at $27.41, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 61.985, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.162, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CAPR at 59.0/100 with a HOLD recommendation.
CAPR (Capricor Therapeutics Inc) Indicators
Last updated Apr 06, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 61.985 |
| CMF (20) | -0.162 |
| ROC (10) | 13.694 |
| ADX (14) | 21.265 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.875 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -1.091 |
| MFI (14) | 31.761 |
CAPR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CAPR Price vs Max Options Open Interest
CAPR Max Change In Options Open Interest
CAPR Options - Sort by Max open Interest (near term)
6th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Daily Out of Money Options - Sort by Max open Interest (near term)
6th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Daily In the Money Options - Sort by Max open Interest (near term)
6th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Most Active Options by Volume(near term)
6th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Capricor Therapeutics Inc is above both 50 Day and 200 Day SMA which is considered Bullish.
CAPR Moving Averages Analysis
Capricor Therapeutics Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 06, 2026
Capricor Therapeutics Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 06, 2026
CAPR (Capricor Therapeutics Inc) Simple Moving Averages
Moving Averages are last updated Apr 06, 2026
| Days | MA |
|---|---|
| 10 | 30.1 |
| 20 | 30.77 |
| 30 | 29.58 |
| 50 | 27.41 |
| 100 | 23.66 |
| 200 | 15.52 |
CAPR Fundamental Analysis
| P/E (Forward) | 78.7402 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -2.26 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.0838 |
| EPS Estimate Next Year ($) | -0.38 |
| WallStreet Target Price ($) | 53.9 |
| Most Recent Quarter |
News: $CAPR stock is climbing after news of potential accelerated approval. Investors are optimistic about the company's future following years of regulatory challenges. The departure of Prasad, who faced sexual harassment charges, is seen as a positive development for the company. Additionally, a StealthX report is expected soon, which could further boost the stock.
Updated 2026-03-07 19:00:01